Condition (MeSH)
Oral Manifestations
ClinicalTrials.gov lists 28 trials for Oral Manifestations or a narrower condition beneath it. Grupo de Estudos Multicentricos em Onco-Hematologia has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
26 of the 28 trials are tagged with Oral Manifestations itself; the rest are tagged with a narrower condition beneath it.
When did Oral Manifestations trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 7 |
| 2019 | 2 |
| 2018 | 3 |
| 2016 | 1 |
| 2013 | 1 |
| 2011 | 1 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Oral Manifestations trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 10 |
| Observational | 16 |
How many Oral Manifestations trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 15 |
| Suspended | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Oral Manifestations trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Grupo de Estudos Multicentricos em Onco-Hematologia | 2 |
| Johnson & Johnson Consumer and Personal Products Worldwide | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
| Septodont | 1 |
Which drugs are being tested for Oral Manifestations? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Clobetasol | 1 |
| Aminocaproic Acid | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Dexamethasone/Dexamethasone acetate | 1 |
| COVID-19 Vaccine | 1 |
| Diagnostic Imaging ( 6α-[18F]fluoro-17β-estradiol (FES)) | 1 |
| Biopsies | 1 |
| A3: Acetaminophen (Tylenol caplets®, from Janssen-Cilag, S.A. de C.V.) | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Oral Manifestations? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Diabetes mellitus and periodontal disease: two-year longitudinal observations. I. | Journal of periodontology | 1970 | Yes |
| Periodontal status during pregnancy. | Journal of periodontology | 1974 | No |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.